HUMA
Humacyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
+0.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 22.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.31x
- Price / sales
- 78.21x
- Price / cash flow
- -1.71x
Enterprise value
- Enterprise value
- $152.2M
- EV / sales
- 71.74x
- EV / EBITDA
- -1.91x
- EV / EBIT
- -1.37x
- Market cap
- $165.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026